HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia.

Abstract
In the present open study the effects of the D1-dopamine antagonist SCH 39166 on positive and negative symptoms of schizophrenia (DSM-IIIR) were investigated. SCH 39166 was given orally according to a fixed dosage schedule (day 1: 25 mg b.i.d; day 4: 50 mg b.i.d.; day 7: 100 mg b.i.d.; day 18: 200 mg b.i.d.; day 21: 225 mg b.i.d.). Seven patients completed 2 weeks, and five patients completed the study. The reason for premature withdrawal was lack of efficacy or refusal to take SCH 39166. In none of the patients a reduction of the BPRS or CGI score was found. As measured with the PANSS, a significant reduction was observed in the score of the negative subscale, whereas the positive symptoms scale and general psychopathology score remained unaffected. Akathisia, rigidity and hypokinesia were reported occasionally, although only mild in severity. The results of the present study do not support the hypothesis that D1-dopamine antagonists are clinically effective antipsychotics in schizophrenia, considering the fact that SCH 39166 had no effect on positive symptoms. The present study provides circumstantial evidence for an effect of SCH 39166 on negative symptoms.
AuthorsJ A Den Boer, H J van Megen, W W Fleischhacker, J W Louwerens, B R Slaap, H G Westenberg, G D Burrows, O N Srivastava
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 121 Issue 3 Pg. 317-22 (Oct 1995) ISSN: 0033-3158 [Print] Germany
PMID8584612 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antipsychotic Agents
  • Dopamine Antagonists
  • Receptors, Dopamine D1
Topics
  • Administration, Oral
  • Adult
  • Antipsychotic Agents (pharmacology)
  • Dopamine Antagonists (therapeutic use)
  • Female
  • Humans
  • Male
  • Psychiatric Status Rating Scales
  • Receptors, Dopamine D1 (antagonists & inhibitors)
  • Schizophrenia (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: